NCT05361694View on ClinicalTrials.gov

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

April 12, 2022

Primary Completion Date

July 1, 2027

Study Completion Date

July 1, 2027

Conditions

Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance

Trial Locations (1)

33136

RECRUITING

University of Miami Hospitals, Miami

All Listed Sponsors

lead

University of Miami

OTHER